Equities

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals Inc

Actions
  • Price (EUR)5.15
  • Today's Change0.10 / 1.98%
  • Shares traded0.00
  • 1 Year change+61.95%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments388467433
Total Receivables, Net343432
Total Inventory1.361.191.03
Prepaid expenses9.171812
Other current assets, total000
Total current assets433519478
Property, plant & equipment, net9.141112
Goodwill, net------
Intangibles, net1211920
Long term investments------
Note receivable - long term------
Other long term assets9.52117.63
Total assets648634594
LIABILITIES
Accounts payable2.414.985.87
Accrued expenses858669
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total----0
Total current liabilities889174
Total long term debt000
Total debt000
Deferred income tax------
Minority interest------
Other liabilities, total161614
Total liabilities10410789
SHAREHOLDERS EQUITY
Common stock0.060.060.06
Additional paid-in capital700686669
Retained earnings (accumulated deficit)(155)(158)(164)
Treasury stock - common------
Unrealized gain (loss)(0.05)(1.19)(0.21)
Other equity, total0.02(0.01)0.03
Total equity545527505
Total liabilities & shareholders' equity648634594
Total common shares outstanding585756
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.